第三代头孢菌素耐药的自发性细菌性腹膜炎发生的预测因素

朱龙川; 甘达凯; 胡青青; 熊墨龙

doi:10.3969/j.issn.1001-5256.2019.07.016

第三代头孢菌素耐药的自发性细菌性腹膜炎发生的预测因素

DOI: 10.3969/j.issn.1001-5256.2019.07.016

南昌市第九医院慢性肝病科，
南昌市第九医院重症肝病科

基金项目:

江西省卫生计生委科技计划(20187071)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1235
- HTML全文浏览量: 67
- PDF下载量: 243
- 被引次数: 0
出版历程
- 收稿日期: 2019-02-26
- 出版日期: 2019-07-20

Predictive factors for third-generation cephalosporin-resistant spontaneous bacterial peritonitis

Department of Severe Liver Disease, The Ninth Hospital of Nanchang, Nanchang 330002, China

Research funding:

摘要

摘要:
目的探讨第三代头孢菌素（3rdGC）耐药的自发性细菌性腹膜炎（3rdGCR SBP）发生的预测因素。方法回顾性收集2010年1月-至2018年12月在南昌市第九医院住院的206例肝硬化患者临床资料,均合并腹水培养单株细菌阳性的SBP。依据药敏结果,腹水病原菌对3rdGC耐药者纳入3rdGCR SBP组（n=101）,敏感者纳入对照组（n=105）。查阅患者电子病历采集各项信息。符合正态分布的计量资料2组间比较采用t检验;偏态分布数据2组间比较采用Mann-Whitney U检验。计数资料2组间比较采用χ2检验或Fisher精确概率法。多因素分析采用二分类Logistic回归,自变量筛选采用Forward:LR法。结果 2组病原菌构成差异有统计学意义（P <0. 001）。单因素分析中,2组间差异有统计学意义的候选预测指标为近3月广谱抗菌素暴露史（χ2=12. 351,P <0. 001）、SBP非首次发病（χ2=14. 427,P <0. 001）、血肌酐（χ2=-2. 537,P...
- 腹膜炎 /
- 头孢菌素类 /
- 头孢菌素抗药性 /
- 因素分析,统计学
Abstract:
Objective To investigate the predictive factors for third-generation cephalosporin-resistant spontaneous bacterial peritonitis ( SBP) . Methods A retrospective analysis was performed for the clinical data of 206 patients with liver cirrhosis who were hospitalized in the Ninth Hospital of Nanchang from January 2010 to December 2018, and all patients had SBP with positive bacteria based on ascites culture. According to drug susceptibility results, the patients were divided into third-generation cephalosporin-resistant SBP group ( 101 patients with third-generation cephalosporin-resistant pathogenic bacteria in ascites) and control group ( 105 patients with pathogenic bacteria sensitive to third-generation cephalosporin) . Electronic medical records were reviewed to collect related information. The t-test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of data with skewed distribution between groups. The chi-square test or the Fisher's exact test was used for comparison of categorical data between groups. A dichotomous logistic regression analysis was used for multivariate analysis, and the Forward: LR method was used for the screening of independent variables. Results There was a significant difference in the composition of pathogenic bacteria between the two groups ( P <0. 001) . The univariate analysis showed that a history of broad-spectrum antibiotic exposure in the past three months ( χ2= 12. 351, P <0. 001) , non-first-time onset of SBP ( χ2= 14. 427, P < 0. 001) , blood creatinine ( χ2=-2. 537, P = 0. 011) , and blood bicarbonate ( χ2=-4. 592, P < 0. 001) were candidate predictive factors with statistical significance between the two groups, and further multivariate analysis showed that a history of broad-spectrum antibiotic exposure in the past three months ( odds ratio [OR]= 2. 376, 95% confidence interval [CI]: 1. 009-5. 598, P = 0. 048) , non-first-time onset of SBP ( OR = 2. 841, 95% CI: 1. 133-7. 122, P = 0. 026) , and blood bicarbonate ( OR = 0. 892, 95% CI: 0. 818-0. 973, P = 0. 010) had an independent predictive value for third-generation cephalosporin-resistant SBP. Conclusion A history of broad-spectrum antibiotic exposure in the past three months, non-first-time onset of SBP, and a low level of blood bicarbonate are independent predictive factors for third-generation cephalosporin-resistant SBP, and third-generation cephalosporins should be used with caution in SBP patients with these features.
- peritonitis /
- cephalosporins /
- cephalosporin resistance /
- factor analysis, statistical

HTML全文

参考文献(18)

[1] DEVER JB, SHEIKH MY. Review article:Spontaneous bacterial peritonitis—bacteriology, diagnosis, treatment, risk factors and prevention[J]. Aliment Pharmacol Ther, 2015, 41 (11) :1116-1131.

[2] ANGELONI S, LEBOFFE C, PARENTE A, et al. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice[J]. World J Gastroenterol, 2008, 14 (17) :2757-2762.

[3] FIORE M, GENTILE I, MARAOLO AE, et al. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2018, 30 (3) :329-336.

[4] JINDAL A, KUMAR M, BHADORIA AS, et al. A randomized open label study of'imipenem vs. cefepime'in spontaneous bacterial peritonitis[J]. Liver Int, 2016, 36 (5) :677-687.

[5] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Chin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[6] European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53 (3) :397-417.

[7] PUGH RN, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60 (8) :646-649.

[8] KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33 (2) :464-470.

[9] ZHU LC, ZHU X, XU L, et al. Pathogenic bacteria in patients with liver cirrhosis and symptomatic bacterial ascites and their drug-resistance features[J]. Guangdong Med J, 2017, 38 (6) :912-915. (in Chinese) 朱龙川, 朱萱, 徐龙, 等.肝硬化并症状性细菌性腹水的病原菌及其耐药特征[J].广东医学, 2017, 38 (6) :912-915.

[10] Chinese Society of Hepatology, Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Chin Hepatol, 2017, 33 (10) :1847-1863. (in Chinese) 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志, 2017, 33 (10) :1847-1863.

[11] RUNYON BA. AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis:Update 2012[EB/OL]. AASLD, 2013, https://www. aasld. org/sites/default/files/guideline_documents/141020_Guideline_Ascites_4UFb_2015. pdf.

[12] GE F, HUNAG LQ, MAO MQ. Risk factors for multidrug-resistant bacterial infection and related prevention and control measures[J]. Chin J Disinfection Sci, 2017, 34 (3) :292-294. (in Chinese) 葛芳, 黄丽晴, 毛美琴.多重耐药菌感染的危险因素与防控措施[J].中国消毒学杂志, 2017, 34 (3) :292-294.

[13] ARIZA X, CASTELLOTE J, LORA-TAMAYO J, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis[J]. J Hepatol, 2012, 56 (4) :825-832.

[14] YANG X, SUN XF, FAN HJ, et al. Logistic regression analysis on risk factors of multi-drug resistant bacteria infection in diabetic foot disease[J]. Chin J Nosocomiol, 2017, 27 (4) :815-818. (in Chinese) 杨雪, 孙晓菲, 范慧洁, 等.糖尿病足患者多药耐药菌感染的危险因素logistic回归分析[J].中华医院感染学杂志, 2017, 27 (4) :815-818.

[15] SHALIMAR, ACHARYA SK. Difficult to treat spontaneous bacterial peritonitis[J]. Trop Gastroenterol, 2013, 34 (1) :7-13.

[16] CHAULK J, CARBONNEAU M, QAMAR H, et al. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis:A single-centre experience and summary of existing studies[J]. Can J Gastroenterol Hepatol, 2014, 28 (2) :83-88.

[17] CHON YE, KIM SU, LEE CK, et al. Community-acquired vs.nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis[J]. Hepatogastroenterology, 2014, 61 (136) :2283-2290.

[18] LI DZ, ZHENG NH, LI HS. Hospital-acquired and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis:Characteristics of pathogenic bacteria and antibiotic resistant differences[J]. Chin J Pract Int Med, 2014, 34 (12) :1210-1211. (in Chinese) 李德周, 郑南红, 李红山.肝硬化合并自发性细菌性腹膜炎医院和社区感染病原菌特征及比较研究[J].中国实用内科杂志, 2014, 34 (12) :1210-1211.

施引文献

资源附件(0)

访问统计